Not logged in? You're viewing the Free tier. Join for free or log in to access your membership content.
Disclaimer: This content is for informational and educational purposes only and should not be construed as financial or investment advice. Always do your own research and consult a licensed financial advisor before making investment decisions.
Disclosure: The author does not hold a position in SNPS.
← Back to Free Index

SNPS

Analysis as of: 2026-05-07
Synopsys, Inc.
Synopsys sells chip-design software, semiconductor interface and subsystem IP, hardware-assisted verification systems, and engineering simulation software spanning silicon to systems.
ai enterprise hardware semiconductors software
Jump to: SummaryAnalysisOpportunityRiskTrendsLE StructureThird Party Analyst Consensus

Summary

Trusted Design Bottleneck, Broader Engineering Wallet
This is a premium workflow franchise that should keep compounding as AI makes chips and engineered systems harder to design, verify, and simulate. The upside is broader silicon-to-systems spend capture; the main limits are China permissioning and already-high expectations.

Analysis

Thesis
Synopsys should keep compounding because AI raises the amount of design, verification, packaging, and simulation work that must pass through trusted, foundry-qualified workflows; Ansys broadens that control point from chips into full engineered systems, supporting durable wallet-share gains even if generic AI compresses lighter software layers.
Last Economy Alignment
Synopsys benefits as AI makes chips and systems harder to design and verify. Its control points are trusted signoff, verification, IP, and simulation workflows with high switching costs, while low commoditization exposure and low agent bypass risk help preserve pricing.
Upgrade to Allocator to also access: Thesis Critique

Opportunity Outlook

Average Implied 5-Year Multiple
1.9x (from 5 most recent analyses)
Reasoning
This looks like premium compounding rather than a moonshot. Core EDA, verification, and IP remain embedded in schedules customers cannot risk, while Ansys expands spend capture into simulation and digital-twin budgets. I see revenue growing faster than the underlying market through mix, cross-sell, and broader workflow ownership, but a large starting valuation and China policy risk limit the chance of an extreme re-rating.
Upgrade to Allocator to also access: Simplified Opportunity Explanation

Risk Assessment

Overall Risk Summary
The main risk is not relevance but capture. Synopsys is well placed as AI increases engineering complexity, yet upside depends on proving that broader silicon-to-systems workflows monetize quickly enough to offset China permissioning risk, post-Ansys integration demands, and a valuation that already prices in a high-quality franchise.
Upgrade to Allocator to also access: Tech Maturity Risk Score, Adoption Timing Risk Score, Moat Strength Risk Score, Capital Needs Risk Score, Regulatory Risk Score, Execution Risk Score, Concentration Risk Score, Unit Economics Risk Score, Valuation Risk Score, Macro Sensitivity Risk Score

Last Economy Structure

AI Industrial Score
0.89
They sit in the trusted checkpoints that AI chip and system teams cannot skip, so harder products can pull more software, IP, verification, and simulation through the same stack. Generic agents may speed some work, but they do not easily replace foundry-qualified signoff or the permission to operate under tighter export rules.
Upgrade to Reader to also access: Score Decomposition, Confidence Level
Upgrade to Allocator to also access: Obsolescence Vectors, Pricing Fragility
Upgrade to Reader to also access: Constraint Benefit Score, Obsolescence Risk Score

Third Party Analyst Consensus

12-Month Price Target
$534.65
Upgrade to Reader to also access: Bull Case, Base Case, Bear Case